Bruker Corp (BRKR) PT Raised to $30 After Monster Beat - Jefferies

Jefferies analyst, Brandon Couillard is more positive on Bruker (NASDAQ: BRKR) after 1Q16 EPS of $0.21 blew away consensus of $0.06 on better operational execution, timing and a lower tax rate. BRKR's self-help initiatives continue to gain traction even though 2016/17 forecasts are largely unchanged. That said, the analyst believes there is greater likelihood of the company beating forecasts in future quarter.

PT moves to $30 (from $28). Buy maintained.

For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.

Shares of Bruker closed at $27.65 yesterday.

You May Also Be Interested In

• Tyra Biosciences (TYRA) PT Lowered to $29 at H.C. Wainwright
• Jefferies Starts Crane NXT (CXT) at Buy, 'Underappreciated Growth and Margin Story'
• Goldman Sachs Upgrades XD Inc (2400:HK) (XDNCF) to Buy